Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.1B | 2.7B | 3.4B | 2.4B |
Cost of revenue | 2.0B | 1.9B | 2.1B | 1.6B |
Gross profit | 1.1B | 828.1M | 1.2B | 870.5M |
Operating expense | ||||
Research & development | 396.2M | 404.6M | 435.9M | 441.5M |
Selling general and admin | 371.5M | -563.6M | 830.4M | -82.1M |
Other operating expenses | 10.2M | 16.9M | 9.2M | 33.2M |
Operating income | 335.0M | 76.2M | 444.9M | 161.8M |
Non operating interest income | ||||
Income | 12.6M | 15.1M | 1.8M | — |
Expense | 4.7M | 27.2M | 23.5M | — |
Other income expense | — | — | — | — |
Pretax income | 391.1M | -516.1M | 179.2M | -182.0M |
Tax provision | 40.2M | -197.2M | 24.3M | -64.5M |
Net income | 350.9M | -318.9M | 154.9M | -117.5M |
Basic EPS | 0.2 | — | — | — |
Diluted EPS | 0.2 | — | — | — |
Basic average shares | 1.6B | — | — | — |
Diluted average shares | 1.6B | — | — | — |
EBITDA | 304.3M | 14.9M | 420.2M | 158.5M |
Net income from continuing op. | — | — | — | — |
Minority interests | 14.3M | -3.5M | -5.7M | 12.3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |